Stada Arzneimittel AG reported a drop in its earnings fell in the first quarter.
Stada's quarterly net profit fell 35% y/y to EUR19.4 million, versus analysts' estimates of EUR25 million. Its sales gained 6% to EUR443.4 million, versus analysts' expectations of EUR455 million.
Earnings before interest, taxes, depreciation, and amortization fell to EUR77.3 million, versus analysts' estimates of EUR86 million. Earnings per share declined 35% y/y to EUR0.33, versus analysts' estimates of EUR0.43.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in